SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Polyrizon Ltd.

Polyrizon Ltd. Ordinary Shares

PLRZ is trending due to positive mucoadhesion data for its intranasal Naloxone program, sparking excitement about its potential as a multi-day runner. Community discussions revolve around the significance of the manufacturing milestone and superior data, while some traders are wary of potential dilution given the company's history and low float. The stock is also gaining attention within the context of other low-float Israeli stocks experiencing significant moves.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending following the release of its Q3 earnings, which beat analyst expectations and showed profitability. The community is actively discussing the company's growth, partnerships, and potential for a continued uptrend, while also debating its valuation relative to peers and the impact of short positions.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to positive Phase 3 results for their DMD treatment, deramiocel, sparking buyout speculation. Community members are discussing potential FDA approval pathways and upcoming catalysts, while biotech shorts appear to be getting squeezed. The conversation highlights optimism around the drug's potential impact on both skeletal and cardiac function in DMD patients.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending as investors react to mixed sentiment surrounding its future growth, despite a low valuation and recent partnerships. Discussions center on whether new initiatives and cost management can offset concerns about slowing growth in its core business, leading to a debate about its potential for a turnaround versus continued stagnation. The community is closely watching for catalysts that could shift market perception, such as upcoming earnings and progress in AI and crypto initiatives.

UP Fintech Holding Ltd. is an online brokerage firm that focuses on global investors. It provides an online trading platform that enables investors to trade in equities and other financial instruments on multiple exchanges around the world. The firm offers products and services, as well as a user experience to customers through its mobile first strategy. The company was founded by Tian Hua Wu in June 2014 and is headquartered in Singapore.

UP Fintech Holding Ltd - ADR

UP Fintech Holding is trending due to strong Q3 earnings with record revenue and profit, sparking community discussion about its undervaluation compared to peers like $HOOD and $FUTU. Investors are actively discussing the company's growth in global client assets and potential as a leading trading platform in Asia. Some are comparing its potential to that of Robinhood.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MLTX is trending amid mixed sentiment following recent trial setbacks and shareholder lawsuits, though analysts see potential upside and key readouts are expected in the coming quarters. Community members are weighing the risks against the potential for a buyout, drawing comparisons to other biotech successes, and closely watching the upcoming FDA meeting for clarity. Discussions also focus on technical analyses, potential market size, and institutional investment activity.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce's recent earnings and future revenue outlook are driving market conversation, though the stock's after-hours volatility has some traders questioning confidence in the name. While some see AI as a potential disruptor to the business, others highlight the company's adoption of AI tools and overall financial health. Community sentiment is mixed, with some expressing frustration over the stock's performance and leadership.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is trending as the community rallies around the revival of OG memes on the Solana blockchain. Community members emphasize consistent engagement and building a strong culture, expressing conviction that $RAGE represents more than just a coin. Discussions highlight the importance of community over charts, with members actively working towards broader recognition and adoption.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending amid discussions of potential catalysts like upcoming earnings and speculation around key figures like Roaring Kitty and Michael Burry. The community is actively dissecting trading patterns, potential gamma ramps, and the impact of large buy orders, while also eyeing the performance of GME warrants. Some traders express frustration with persistent price suppression despite positive fundamentals and potential short squeezes.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid speculation and bidding wars for Warner Bros. Discovery assets, with community members discussing potential outcomes and impacts on the stock. Some traders are analyzing technical indicators, while others express concerns about the company's direction or praise its long-term potential. A mostly cash offer from Netflix is a key point of discussion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Decheng Capital LLC Has $1.30 Million Holdings in Arcus Biosciences, Inc. $RCUS

Decheng Capital LLC decreased its position in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 80.2% in the 2nd quarter, according to the company in its most recent 13F filing with the...

Alexander Azoy Sells 1,900 Shares of Arcus Biosciences (NYSE:RCUS) Stock

Arcus Biosciences, Inc. (NYSE:RCUS - Get Free Report) CAO Alexander Azoy sold 1,900 shares of the stock in a transaction that occurred on Wednesday, November 26th. The shares were sold at an average...

Arcus Biosciences (NYSE:RCUS) Stock Price Expected to Rise, Bank of America Analyst Says

Bank of America raised their target price on shares of Arcus Biosciences from $17.00 to $26.00 and gave the stock a "neutral" rating in a report on Friday...

Arcus Biosciences (NYSE:RCUS) Hits New 12-Month High - Still a Buy?

Arcus Biosciences (NYSE:RCUS) Hits New 1-Year High - Here's Why...

Arcus Biosciences (NYSE:RCUS) Upgraded to "Hold" at Wall Street Zen

Wall Street Zen raised shares of Arcus Biosciences from a "sell" rating to a "hold" rating in a research report on Saturday...

Arcus Biosciences (NYSE:RCUS) Trading Up 5.1% - What's Next?

Arcus Biosciences (NYSE:RCUS) Trading Up 5.1% - Here's What Happened...

Arcus Biosciences (NYSE:RCUS) President Sells $99,737.50 in Stock

Arcus Biosciences, Inc. (NYSE:RCUS - Get Free Report) President Juan Jaen sold 5,050 shares of the business's stock in a transaction on Tuesday, November 18th. The shares were sold at an average...

Insider Selling: Arcus Biosciences (NYSE:RCUS) President Sells 44,950 Shares of Stock

Arcus Biosciences, Inc. (NYSE:RCUS - Get Free Report) President Juan Jaen sold 44,950 shares of the stock in a transaction on Monday, November 17th. The stock was sold at an average price of $20.31...

Arcus Biosciences (NYSE:RCUS) President Juan Jaen Sells 5,050 Shares

Arcus Biosciences, Inc. (NYSE:RCUS - Get Free Report) President Juan Jaen sold 5,050 shares of the company's stock in a transaction on Tuesday, November 18th. The stock was sold at an average price...

Arcus Biosciences, Inc. (NYSE:RCUS) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Arcus Biosciences, Inc. (NYSE:RCUS - Get Free Report) have been given an average recommendation of "Moderate Buy" by the ten research firms that are covering the firm, MarketBeat reports...

Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology, and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$1.14	--	--	N/A
Q3 '25	-$1.31	-$1.27	3.05%	BEAT
Q2 '25	-$1.13	-$1.11	1.85%	BEAT
Q1 '25	-$1.03	-$1.14	-10.57%	MISSED
Q4 '24	-$1.25	-$1.03	17.52%	BEAT

RCUS
Arcus Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest RCUS News

RCUSArcus Biosciences Inc